Immunotherapy prototype Mark 3.0 model in primary liver cancer: adding locoregional stereotactic therapy and prognostic factors classification management

Immune checkpoint inhibitors (ICIs) like programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitor have shown considerable efficacy in several important cancers including primary liver cancer (PLC) like hepatocellular carcinoma and cholangiocarcinoma. However, only some patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xu, Zhang, Nan, Song, Yang, Yang, Xiaobo, Sang, Xinting, Zhao, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471086/
https://www.ncbi.nlm.nih.gov/pubmed/37724259
http://dx.doi.org/10.1515/mr-2022-0045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471086/
https://www.ncbi.nlm.nih.gov/pubmed/37724259
http://dx.doi.org/10.1515/mr-2022-0045

Ejemplares similares